BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 34299164)

  • 1. How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
    Sainz-Ramos M; Gallego I; Villate-Beitia I; Zarate J; Maldonado I; Puras G; Pedraz JL
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
    Ediriweera GR; Chen L; Yerbury JJ; Thurecht KJ; Vine KL
    Mol Pharm; 2021 Jun; 18(6):2142-2160. PubMed ID: 34010004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development of Functional Non-Viral Vectors for Gene Delivery.
    Patil S; Gao YG; Lin X; Li Y; Dang K; Tian Y; Zhang WJ; Jiang SF; Qadir A; Qian AR
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress of nucleic acid delivery vectors for gene therapy.
    Jiao Y; Xia ZL; Ze LJ; Jing H; Xin B; Fu S
    Biomed Microdevices; 2020 Jan; 22(1):16. PubMed ID: 31989315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical translation of gene medicine.
    Wang F; Qin Z; Lu H; He S; Luo J; Jin C; Song X
    J Gene Med; 2019 Jul; 21(7):e3108. PubMed ID: 31246328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide gene transfection agents.
    Khan W; Hosseinkhani H; Ickowicz D; Hong PD; Yu DS; Domb AJ
    Acta Biomater; 2012 Dec; 8(12):4224-32. PubMed ID: 23022542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphene materials as 2D non-viral gene transfer vector platforms.
    Vincent M; de Lázaro I; Kostarelos K
    Gene Ther; 2017 Mar; 24(3):123-132. PubMed ID: 27874854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.
    Zhou Z; Liu X; Zhu D; Wang Y; Zhang Z; Zhou X; Qiu N; Chen X; Shen Y
    Adv Drug Deliv Rev; 2017 Jun; 115():115-154. PubMed ID: 28778715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosis in gene therapy with non-viral vectors.
    Perez Ruiz de Garibay A
    Wien Med Wochenschr; 2016 May; 166(7-8):227-35. PubMed ID: 27141862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ocular disorders by gene therapy.
    Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary approaches for nonviral gene therapy.
    Jones CH; Hill A; Chen M; Pfeifer BA
    Discov Med; 2015 Jun; 19(107):447-54. PubMed ID: 26175402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
    Mansouri S; Lavigne P; Corsi K; Benderdour M; Beaumont E; Fernandes JC
    Eur J Pharm Biopharm; 2004 Jan; 57(1):1-8. PubMed ID: 14729076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vectors for gene delivery and gene therapy within the endocrine system.
    Stone D; David A; Bolognani F; Lowenstein PR; Castro MG
    J Endocrinol; 2000 Feb; 164(2):103-18. PubMed ID: 10657846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases (review).
    Athanasopoulos T; Fabb S; Dickson G
    Int J Mol Med; 2000 Oct; 6(4):363-75. PubMed ID: 10998427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting.
    Walther W; Stein U
    J Mol Med (Berl); 1996 Jul; 74(7):379-92. PubMed ID: 8841950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.
    Hill AB; Chen M; Chen CK; Pfeifer BA; Jones CH
    Trends Biotechnol; 2016 Feb; 34(2):91-105. PubMed ID: 26727153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of current delivery systems in cancer gene therapy.
    El-Aneed A
    J Control Release; 2004 Jan; 94(1):1-14. PubMed ID: 14684267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of human disease by adeno-associated viral gene transfer.
    Warrington KH; Herzog RW
    Hum Genet; 2006 Jul; 119(6):571-603. PubMed ID: 16612615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.
    Chis AA; Dobrea CM; Rus LL; Frum A; Morgovan C; Butuca A; Totan M; Juncan AM; Gligor FG; Arseniu AM
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.